References
Engel AG (1986) Carnitine deficiency syndromes and lipid storage myopathies. In: Engel AG, Banker BQ (eds) Myology, basic and clinical, vol 2. McGraw-Hill, New York, pp 1663–1696
Kuntzer T, Bogousslavsky J, Deruaz JP, Janzer P, Regli F (1989) Reversible emetine-induced myopathy with ECG abnormalities: a toxic myopathy. J Neurol 236:246–248
McGarry JD, Foster DW (1976) An improved and simplified radioisotope assay for the determination of free and esterified carnitine. J Lipid Res 17:277–281
Palmer EP, Guay AT (1985) Reversible myopathy secondary to abuse of ipecac in patients with major eating disorders. N Engl J Med 313:1457–1459
Reichmann H, Srihari T, Pette D (1983) Ipsi- and contralateral fibre transformation by cross-reinnervation. A principle of symmetry. Pflügers Arch 397:202–208
Reichmann H, Rohkamm R, Zeviani M, Servidei S, Ricker K, DiMauro S (1986) Mitochondrial myopathy due to complex III deficiency with normal reducible cytochrome B concentration. Arch Neurol 43:957–961
Rollo IM (1975) Drugs used in chemotherapy of amebiasis. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics. Macmillan, New York, pp 1074–1078
Sugie H, Russin R, Verity A (1984) Emetine myopathy: two case reports with pathobiochemical analysis. Muscle Nerve 7:54–59
Victor M (1986) Toxic and nutritional myopathies. In: Engel AG, Banker BQ (eds) Myology, basic and clinical, vol 2. McGraw-Hill, New York, pp 1807–1842
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kuntzer, T., Reichmann, H., Bogousslavsky, J. et al. Emetine-induced myopathy and carnitine deficiency. J Neurol 237, 495–496 (1990). https://doi.org/10.1007/BF00314772
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00314772